Skip to main content
Top
Published in: BMC Neurology 1/2021

Open Access 01-12-2021 | Stroke | Research article

Persistent hyperglycemia is a useful glycemic pattern to predict stroke mortality: a systematic review and meta-analysis

Authors: Duanlu Hou, Ping Zhong, Xiaofei Ye, Danhong Wu

Published in: BMC Neurology | Issue 1/2021

Login to get access

Abstract

Background

Glycemic patterns have been reported to be prognostic factors for stroke; however, this remains to be further evaluated. This meta-analysis aimed to evaluate the usefulness of glycemic patterns such as persistent hyperglycemia (PH) including short duration and long duration PH (SPH; LPH), admission hyperglycemia (AH), short-duration hyperglycemia (SH), and persistent normoglycemia (PN) in predicting stroke prognosis using published results.

Methods

Major scientific databases including but are not limited to PubMed, EMBASE, Web of Science, Ovid, CNKI (Chinese National Knowledge Infrastructure), and Clinicaltrials.​gov were searched till 1st March 2021 for clinical trials on the correlation between glycemic patterns and stroke outcomes. The primary outcome was defined as short-term (1- or 3-month) post-stroke mortality, and the secondary outcome was post-stroke hemorrhage at 6 months.

Results

Ten studies involving 3584 individuals were included in the final analysis. In subgroup analyses, PH patients with no history of diabetes had increased post-stroke mortality (odds ratio [OR]: 4.80, 95% CI: 3.06–7.54) than patients with no PH; and patients with glucose levels > 140 mg/dl had greater mortality (OR: 5.12, 95% CI: 3.21–8.18) than those with glucose levels < 140 mg/dl; compared with AH patients, PH patients had increased short-term mortality (OR: 0.31, 95% CI: 0.16–0.60). In the prediction of stroke mortality among patients without diabetes, SPH (OR: 0.28, 95%CI: 0.12–0.69) seemed to be more related to increased mortality than LPH (OR: 0.35, 95% CI: 0.14–-0.90).

Conclusions

PH, especially SPH, could predict increased post-stroke mortality in non-diabetic patients. The rank of individual glycemic patterns in predicting stroke mortality in non-diabetic patients was SPH > LPH > AH > PN.
Appendix
Available only for authorised users
Literature
1.
go back to reference Feigin VL, Norrving B, Mensah GA. Global burden of stroke. Circ Res. 2017;120(3):439–48.CrossRef Feigin VL, Norrving B, Mensah GA. Global burden of stroke. Circ Res. 2017;120(3):439–48.CrossRef
2.
go back to reference Gattringer T, Posekany A, Niederkorn K, Knoflach M, Poltrum B, Mutzenbach S, et al. Predicting early mortality of acute ischemic stroke. Stroke. 2019;50(2):349–56.CrossRef Gattringer T, Posekany A, Niederkorn K, Knoflach M, Poltrum B, Mutzenbach S, et al. Predicting early mortality of acute ischemic stroke. Stroke. 2019;50(2):349–56.CrossRef
3.
go back to reference Fuentes B, Castillo J, San Jose B, Leira R, Serena J, Vivancos J, et al. The prognostic value of capillary glucose levels in acute stroke: the GLycemia in acute stroke (GLIAS) study. Stroke. 2009;40(2):562–8.CrossRef Fuentes B, Castillo J, San Jose B, Leira R, Serena J, Vivancos J, et al. The prognostic value of capillary glucose levels in acute stroke: the GLycemia in acute stroke (GLIAS) study. Stroke. 2009;40(2):562–8.CrossRef
4.
go back to reference Luitse MJ, van Seeters T, Horsch AD, Kool HA, Velthuis BK, Kappelle LJ, et al. Admission hyperglycaemia and cerebral perfusion deficits in acute ischaemic stroke. Cerebrovasc Dis. 2013;35(2):163–7.CrossRef Luitse MJ, van Seeters T, Horsch AD, Kool HA, Velthuis BK, Kappelle LJ, et al. Admission hyperglycaemia and cerebral perfusion deficits in acute ischaemic stroke. Cerebrovasc Dis. 2013;35(2):163–7.CrossRef
5.
go back to reference Lau LH, Lew J, Borschmann K, Thijs V, Ekinci EI. Prevalence of diabetes and its effects on stroke outcomes: a meta-analysis and literature review. J Diab Investig. 2019;10(3):780–92.CrossRef Lau LH, Lew J, Borschmann K, Thijs V, Ekinci EI. Prevalence of diabetes and its effects on stroke outcomes: a meta-analysis and literature review. J Diab Investig. 2019;10(3):780–92.CrossRef
6.
go back to reference Rinkel LA, Nguyen TTM, Guglielmi V, Groot AE, Posthuma L, Roos Y, et al. High admission glucose is associated with poor outcome after endovascular treatment for ischemic stroke. Stroke. 2020;51(11):3215–23.CrossRef Rinkel LA, Nguyen TTM, Guglielmi V, Groot AE, Posthuma L, Roos Y, et al. High admission glucose is associated with poor outcome after endovascular treatment for ischemic stroke. Stroke. 2020;51(11):3215–23.CrossRef
7.
go back to reference Qureshi AI, Palesch YY, Martin R, Novitzke J, Cruz-Flores S, Ehtisham A, et al. Association of serum glucose concentrations during acute hospitalization with hematoma expansion, perihematomal edema, and three month outcome among patients with intracerebral hemorrhage. Neurocrit Care. 2011;15(3):428–35.CrossRef Qureshi AI, Palesch YY, Martin R, Novitzke J, Cruz-Flores S, Ehtisham A, et al. Association of serum glucose concentrations during acute hospitalization with hematoma expansion, perihematomal edema, and three month outcome among patients with intracerebral hemorrhage. Neurocrit Care. 2011;15(3):428–35.CrossRef
8.
go back to reference Wu TY, Putaala J, Sharma G, Strbian D, Tatlisumak T, Davis SM, et al. Persistent hyperglycemia is associated with increased mortality after Intracerebral hemorrhage. J Am Heart Assoc. 2017;6(8):1–10.CrossRef Wu TY, Putaala J, Sharma G, Strbian D, Tatlisumak T, Davis SM, et al. Persistent hyperglycemia is associated with increased mortality after Intracerebral hemorrhage. J Am Heart Assoc. 2017;6(8):1–10.CrossRef
9.
go back to reference Merlino G, Smeralda C, Sponza M, Gigli GL, Lorenzut S, Marini A, et al. Dynamic hyperglycemic patterns predict adverse outcomes in patients with acute ischemic stroke undergoing mechanical thrombectomy. J Clin Med. 2020;9(6):1–13.CrossRef Merlino G, Smeralda C, Sponza M, Gigli GL, Lorenzut S, Marini A, et al. Dynamic hyperglycemic patterns predict adverse outcomes in patients with acute ischemic stroke undergoing mechanical thrombectomy. J Clin Med. 2020;9(6):1–13.CrossRef
10.
go back to reference Yong M, Kaste M. Dynamic of hyperglycemia as a predictor of stroke outcome in the ECASS-II trial. Stroke. 2008;39(10):2749–55.CrossRef Yong M, Kaste M. Dynamic of hyperglycemia as a predictor of stroke outcome in the ECASS-II trial. Stroke. 2008;39(10):2749–55.CrossRef
11.
go back to reference Ntaios G, Abatzi C, Alexandrou M, Lambrou D, Chatzopoulos S, Egli M, et al. Persistent hyperglycemia at 24-48 h in acute hyperglycemic stroke patients is not associated with a worse functional outcome. Cerebrovasc Dis. 2011;32(6):561–6.CrossRef Ntaios G, Abatzi C, Alexandrou M, Lambrou D, Chatzopoulos S, Egli M, et al. Persistent hyperglycemia at 24-48 h in acute hyperglycemic stroke patients is not associated with a worse functional outcome. Cerebrovasc Dis. 2011;32(6):561–6.CrossRef
12.
go back to reference Fuentes B, Ortega-Casarrubios MA, Sanjose B, Castillo J, Leira R, Serena J, et al. Persistent hyperglycemia >155 mg/dL in acute ischemic stroke patients: how well are we correcting it?: implications for outcome. Stroke. 2010;41(10):2362–5.CrossRef Fuentes B, Ortega-Casarrubios MA, Sanjose B, Castillo J, Leira R, Serena J, et al. Persistent hyperglycemia >155 mg/dL in acute ischemic stroke patients: how well are we correcting it?: implications for outcome. Stroke. 2010;41(10):2362–5.CrossRef
13.
go back to reference Baird TA, Parsons MW, Phan T, Butcher KS, Desmond PM, Tress BM, et al. Persistent poststroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome. Stroke. 2003;34(9):2208–14.CrossRef Baird TA, Parsons MW, Phan T, Butcher KS, Desmond PM, Tress BM, et al. Persistent poststroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome. Stroke. 2003;34(9):2208–14.CrossRef
14.
go back to reference Mi D, Wang P, Yang B, Pu Y, Yang Z, Liu L. Correlation of hyperglycemia with mortality after acute ischemic stroke. Ther Adv Neurol Disord. 2018;11:1756285617731686.CrossRef Mi D, Wang P, Yang B, Pu Y, Yang Z, Liu L. Correlation of hyperglycemia with mortality after acute ischemic stroke. Ther Adv Neurol Disord. 2018;11:1756285617731686.CrossRef
15.
go back to reference Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535.CrossRef Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535.CrossRef
16.
go back to reference Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in EpidemiologyA proposal for reporting. JAMA. 2000;283(15):2008–12.CrossRef Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in EpidemiologyA proposal for reporting. JAMA. 2000;283(15):2008–12.CrossRef
17.
go back to reference Feng W, Tauhid S, Goel S, Sidorov EV, Selim M. Hyperglycemia and outcome in intracerebral hemorrhage: from bedside to bench-more study is needed. Transl Stroke Res. 2012;3(Suppl 1):113–8.CrossRef Feng W, Tauhid S, Goel S, Sidorov EV, Selim M. Hyperglycemia and outcome in intracerebral hemorrhage: from bedside to bench-more study is needed. Transl Stroke Res. 2012;3(Suppl 1):113–8.CrossRef
18.
go back to reference Hou D, Wang C, Ye X, Zhong P, Wu D. Persistent inflammation worsens short-term outcomes in massive stroke patients. BMC Neurol. 2021;21(1):62.CrossRef Hou D, Wang C, Ye X, Zhong P, Wu D. Persistent inflammation worsens short-term outcomes in massive stroke patients. BMC Neurol. 2021;21(1):62.CrossRef
19.
go back to reference Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603–5.CrossRef Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603–5.CrossRef
20.
go back to reference Dziedzic T, Pera J, Trabka-Janik E, Szczudlik A, Slowik A. The impact of postadmission glycemia on stroke outcome: glucose normalisation is associated with better survival. Atherosclerosis. 2010;211(2):584–8.CrossRef Dziedzic T, Pera J, Trabka-Janik E, Szczudlik A, Slowik A. The impact of postadmission glycemia on stroke outcome: glucose normalisation is associated with better survival. Atherosclerosis. 2010;211(2):584–8.CrossRef
21.
go back to reference Li G, Wang C. Predictive value of hyperglycaemia in the prognosis of ischaemic cerebrovascular disease. J Shandong Univ (health science). 2010;48(4):1–4. Li G, Wang C. Predictive value of hyperglycaemia in the prognosis of ischaemic cerebrovascular disease. J Shandong Univ (health science). 2010;48(4):1–4.
22.
go back to reference Scott J, Robinson GM, French JM, O’Connell JE, Alberti KGMM, Gray CS. Prevalence of admission hyperglycaemia across clinical subtypes of acute stroke. Lancet (London, England). 1999;353:376–7.CrossRef Scott J, Robinson GM, French JM, O’Connell JE, Alberti KGMM, Gray CS. Prevalence of admission hyperglycaemia across clinical subtypes of acute stroke. Lancet (London, England). 1999;353:376–7.CrossRef
23.
go back to reference Sulaiman W, Hashim HZ, Abdullah STC, Hoo FK, Basri H. Managing post stroke hyperglycaemia: moderate glycaemic control is better? An update. EXCLI J. 2014;13:825–33. Sulaiman W, Hashim HZ, Abdullah STC, Hoo FK, Basri H. Managing post stroke hyperglycaemia: moderate glycaemic control is better? An update. EXCLI J. 2014;13:825–33.
24.
go back to reference Kruyt ND, Nys GM, van der Worp HB, van Zandvoort MJ, Kappelle LJ, Biessels GJ. Hyperglycemia and cognitive outcome after ischemic stroke. J Neurol Sci. 2008;270(1–2):141–7.CrossRef Kruyt ND, Nys GM, van der Worp HB, van Zandvoort MJ, Kappelle LJ, Biessels GJ. Hyperglycemia and cognitive outcome after ischemic stroke. J Neurol Sci. 2008;270(1–2):141–7.CrossRef
25.
go back to reference Putaala J, Sairanen T, Meretoja A, Lindsberg PJ, Tiainen M, Liebkind R, et al. Post-thrombolytic hyperglycemia and 3-month outcome in acute ischemic stroke. Cerebrovasc Dis. 2011;31(1):83–92.CrossRef Putaala J, Sairanen T, Meretoja A, Lindsberg PJ, Tiainen M, Liebkind R, et al. Post-thrombolytic hyperglycemia and 3-month outcome in acute ischemic stroke. Cerebrovasc Dis. 2011;31(1):83–92.CrossRef
26.
go back to reference Mandava P, Martini SR, Munoz M, Dalmeida W, Sarma AK, Anderson JA, et al. Hyperglycemia worsens outcome after rt-PA primarily in the large-vessel occlusive stroke subtype. Transl Stroke Res. 2014;5(4):519–25.CrossRef Mandava P, Martini SR, Munoz M, Dalmeida W, Sarma AK, Anderson JA, et al. Hyperglycemia worsens outcome after rt-PA primarily in the large-vessel occlusive stroke subtype. Transl Stroke Res. 2014;5(4):519–25.CrossRef
27.
go back to reference Zewde YZ, Mengesha AT, Gebreyes YF, Naess H. The frequency and impact of admission hyperglycemia on short term outcome of acute stroke patients admitted to Tikur Anbessa specialized hospital, Addis Ababa, Ethiopia: a cross-sectional study. BMC Neurol. 2019;19(1):342.CrossRef Zewde YZ, Mengesha AT, Gebreyes YF, Naess H. The frequency and impact of admission hyperglycemia on short term outcome of acute stroke patients admitted to Tikur Anbessa specialized hospital, Addis Ababa, Ethiopia: a cross-sectional study. BMC Neurol. 2019;19(1):342.CrossRef
28.
go back to reference Gray CS, Hildreth AJ, Sandercock PA, O'Connell JE, Johnston DE, Cartlidge NEF, et al. Glucose-potassium-insulin infusions in the management of post-stroke hyperglycaemia: the UK glucose insulin in stroke trial (GIST-UK). Lancet Neurol. 2007;6(5):397–406.CrossRef Gray CS, Hildreth AJ, Sandercock PA, O'Connell JE, Johnston DE, Cartlidge NEF, et al. Glucose-potassium-insulin infusions in the management of post-stroke hyperglycaemia: the UK glucose insulin in stroke trial (GIST-UK). Lancet Neurol. 2007;6(5):397–406.CrossRef
29.
go back to reference Allport L, Baird T, Butcher K, Macgregor L, Prosser J, Colman P, et al. Frequency and temporal profile of poststroke hyperglycemia using continuous glucose monitoring. Diabetes Care. 2006;29(8):1839–44.CrossRef Allport L, Baird T, Butcher K, Macgregor L, Prosser J, Colman P, et al. Frequency and temporal profile of poststroke hyperglycemia using continuous glucose monitoring. Diabetes Care. 2006;29(8):1839–44.CrossRef
30.
go back to reference Kruyt ND, Biessels GJ, Devries JH, Roos YB. Hyperglycemia in acute ischemic stroke: pathophysiology and clinical management. Nat Rev Neurol. 2010;6(3):145–55.CrossRef Kruyt ND, Biessels GJ, Devries JH, Roos YB. Hyperglycemia in acute ischemic stroke: pathophysiology and clinical management. Nat Rev Neurol. 2010;6(3):145–55.CrossRef
31.
go back to reference Capes SE, Hunt D, Malmberg K, Pathak P. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients a systematic overview. Stroke. 2001;32(10):2426–32.CrossRef Capes SE, Hunt D, Malmberg K, Pathak P. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients a systematic overview. Stroke. 2001;32(10):2426–32.CrossRef
32.
go back to reference Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018;14(2):88–98.CrossRef Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018;14(2):88–98.CrossRef
33.
go back to reference Tziomalos K, Dimitriou P, Bouziana SD, Spanou M, Kostaki S, Angelopoulou SM, et al. Stress hyperglycemia and acute ischemic stroke in-hospital outcome. Metabolism. 2017;67:99–105.CrossRef Tziomalos K, Dimitriou P, Bouziana SD, Spanou M, Kostaki S, Angelopoulou SM, et al. Stress hyperglycemia and acute ischemic stroke in-hospital outcome. Metabolism. 2017;67:99–105.CrossRef
34.
go back to reference Scheen AJ. Central nervous system: a conductor orchestrating metabolic regulations harmed by both hyperglycaemia and hypoglycaemia. Diabetes Metab. 2010;36:S31–8.CrossRef Scheen AJ. Central nervous system: a conductor orchestrating metabolic regulations harmed by both hyperglycaemia and hypoglycaemia. Diabetes Metab. 2010;36:S31–8.CrossRef
35.
go back to reference Mergenthaler P, Lindauer U, Dienel GA, Meisel A. Sugar for the brain: the role of glucose in physiological and pathological brain function. Trends Neurosci. 2013;36(10):587–97.CrossRef Mergenthaler P, Lindauer U, Dienel GA, Meisel A. Sugar for the brain: the role of glucose in physiological and pathological brain function. Trends Neurosci. 2013;36(10):587–97.CrossRef
36.
go back to reference Mergenthaler P, Kahl A, Kamitz A, van Laak V, Stohlmann K, Thomsen S, et al. Mitochondrial hexokinase II (HKII) and phosphoprotein enriched in astrocytes (PEA15) form a molecular switch governing cellular fate depending on the metabolic state. Proc Natl Acad Sci U S A. 2012;109(5):1518–23.CrossRef Mergenthaler P, Kahl A, Kamitz A, van Laak V, Stohlmann K, Thomsen S, et al. Mitochondrial hexokinase II (HKII) and phosphoprotein enriched in astrocytes (PEA15) form a molecular switch governing cellular fate depending on the metabolic state. Proc Natl Acad Sci U S A. 2012;109(5):1518–23.CrossRef
37.
go back to reference Fattorusso V, Nugnes R, Casertano A, Valerio G, Mozzillo E, Franzese A. Non-diabetic hyperglycemia in the pediatric age: why, how, and when to treat? Curr Diab Rep. 2018;18(12):140.CrossRef Fattorusso V, Nugnes R, Casertano A, Valerio G, Mozzillo E, Franzese A. Non-diabetic hyperglycemia in the pediatric age: why, how, and when to treat? Curr Diab Rep. 2018;18(12):140.CrossRef
38.
go back to reference Faustino EV, Apkon M. Persistent hyperglycemia in critically ill children. J Pediatr. 2005;146(1):30–4.CrossRef Faustino EV, Apkon M. Persistent hyperglycemia in critically ill children. J Pediatr. 2005;146(1):30–4.CrossRef
Metadata
Title
Persistent hyperglycemia is a useful glycemic pattern to predict stroke mortality: a systematic review and meta-analysis
Authors
Duanlu Hou
Ping Zhong
Xiaofei Ye
Danhong Wu
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Neurology / Issue 1/2021
Electronic ISSN: 1471-2377
DOI
https://doi.org/10.1186/s12883-021-02512-1

Other articles of this Issue 1/2021

BMC Neurology 1/2021 Go to the issue